PPAR Agonist Treatment for Alcohol-Induced Brain Damage

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments lack effective methods for addressing alcohol-induced brain damage and fetal alcohol syndrome, particularly in preventing or reversing cognitive impairment and insulin resistance caused by chronic alcohol intake.

Innovation Solution

Administration of peroxisome proliferator activated receptor (PPAR) agonists to inhibit oxidative stress and DNA damage in the brain, thereby treating, preventing, or reversing alcohol-induced brain damage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments are used for alcohol-induced brain damage, then existing therapeutic options are limited, but effective treatment outcomes are not achieved

Engineering Contradiction:

Improvetreatment effectivenessVSAvoidavailability of treatment options

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies parameter changes by administering PPAR agonists to alter the biochemical parameters in the brain, specifically targeting oxidative stress pathways and insulin signaling. This changes the physiological state of brain tissue to promote survival and repair mechanisms, thereby improving treatment effectiveness where conventional options failed.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The PPAR agonist acts as an intermediary substance that mediates between the harmful effects of alcohol and the brain's protective mechanisms. By activating PPAR receptors, the agonist triggers downstream protective pathways including antioxidant responses and anti-apoptotic signals, serving as a bridge to counteract alcohol-induced damage.

Inventive Principle:

Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If PPAR agonists are administered to treat alcohol-induced brain damage, then brain injury is reduced and ongoing damage is prevented, but the mechanism involves complex biochemical pathways

Engineering Contradiction:

Improvebrain injury extentVSAvoidbiochemical mechanism complexity

Core Design Contradiction:

Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent converts the harmful oxidative stress response into a beneficial protective mechanism by activating PPAR receptors. The same oxidative pathways that cause damage during alcohol metabolism are redirected through PPAR activation to produce antioxidant enzymes and protective proteins, transforming the harmful process into a therapeutic benefit.

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent extracts and isolates the specific PPAR signaling pathway from the complex web of alcohol-induced biochemical changes. By targeting this single receptor family, the treatment separates the beneficial protective signaling from the harmful oxidative stress, allowing selective intervention without needing to address every aspect of the complex biochemical cascade.

Inventive Principle:

Principle #2Taking out (Extraction)

3Strength

If insulin and IGF signaling pathways are targeted, then neuronal survival and plasticity are improved, but the pathways are already compromised by alcohol intake

Engineering Contradiction:

Improveneuronal survival capacityVSAvoidsignaling pathway function

Core Design Contradiction:

StrengthVSReliability

Solution Approach 1:

The patent applies preliminary action by activating PPAR receptors before alcohol-induced damage becomes irreversible. The PPAR agonist pre-conditions the brain cells by upregulating protective proteins and enhancing antioxidant defenses in advance, creating a reservoir of cellular protection that can withstand subsequent alcohol exposure and support neuronal survival.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The treatment establishes a feedback loop where PPAR activation enhances insulin and IGF signaling, which in turn further stimulates PPAR activity. This positive feedback amplifies the protective effects, creating a self-reinforcing cycle of neuronal protection and survival that overcomes the initial suppression caused by alcohol intake.

Inventive Principle:

Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

PPAR agonists significantly reduce brain injury and prevent ongoing damage in animal models, offering a potential therapeutic approach for both adult and fetal alcohol-related brain issues.

Implementation Method 1

administration of a peroxisome proliferator activated receptor (PPAR) agonist

Methodology Applied

Scientific EffectPPAR agonist activation:

Data Source

PatentUS9308198B2Treatment, prevention, and reversal of alcohol-induced brain disease

Publication Date: 2016.04.12 RHODE ISLAND HOSPITAL

AI summary

This invention relates to methods for treating, preventing, or reversing brain disease or damage produced by chronic alcohol intake by administering a peroxisome proliferator activated receptor (PPAR) agonist.